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The stomach epithelium contains a myriad of enteroendocrine cells that modulate a range of
physiological functions, including postprandial secretion of regulatory peptides, gastric motility,
and nutrient absorption. Somatostatin (SST)-producing D-cells are present in the oxyntic and py-
loric regions of the stomach, and provide a tonic inhibitory tone that regulates activity of neigh-
boringenteroendocrine cells andgastric acid secretion. Cellularmechanismsunderlying theeffects
of regulatory factors on gastric D-cells are poorly defined due to problems in identifying primary
D-cells, and uncertainty remains about which stimuli influence D-cells directly. In this study, we
introduce a transgenic mouse line, SST-Cre, which upon crossing with Cre reporter strains, facili-
tates the identification and purification of gastric D-cells, or cell-specific expression of genetically
encoded calcium indicators. Populations of D-cells from the gastric antrum and corpus were iso-
lated and analyzed by RNA sequencing and quantitative RT-PCR. The expression of hormones,
hormone receptors, neurotransmitter receptors, and nutrient receptors was quantified. Pyy,Gipr,
Chrm4,Calcrl,Taar1, andCasrwere identifiedasgenes that arehighly enriched inD-cells compared
with SST-negative cells. Hormone secretion assays performed in mixed gastric epithelial cultures
confirmed that SST secretion is regulated by incretin hormones, cholecystokinin, acetylcholine,
vasoactive intestinal polypeptide, calcitonin gene-related polypeptide, oligopetides, and trace
amines. Cholecystokinin and oligopeptides elicited increases in intracellular calcium in single-cell
imaging experiments performed using cultured D-cells. Our data provide the first transcriptomic
analysis and functional characterization of gastric D-cells, and identify regulatory pathways that
underlie the direct detection of stimuli by this cell type. (Endocrinology 156: 3924–3936, 2015)
The enteroendocrine system of the gastrointestinal (GI)tract is recognized to be the largest endocrine organ in
the body. Composed of varying types of enteroendocrine
cells (EECs) working in concert, it plays a major role in
mediating postprandial secretion of regulatory peptides,
gastric motility, and nutrient absorption (1). Due to their
position in themucosa of the GI tract, EECs are in a prime
location for relaying the composition of luminal contents
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locally and to other areas of the body through a range of
paracrine and endocrine signals. The somatostatin (SST)-
producingD-cell is anEECof particular interest due to the
profound inhibition exerted by SST over other EECs (2),
highlightingD-cells as criticalmodulators of the enteroen-
docrine axis.
Although produced in various areas of the body, in-
cluding the hypothalamus, pancreas, and nerve fibers of
the GI tract, the major site of SST production is gut mu-
cosal D-cells (3, 4). The tonic inhibitory tone provided by
D-cells is known to regulate smooth muscle contractility,
nutrient absorption, and the secretion of key regulatory
hormones (5–9). In the stomach, the main site of SST pro-
duction in the gut, a primary role of SST is to regulate
intragastric pH via restricting gastric acid secretion (2).
Located inboth theoxyntic andpyloric glandsof the stom-
ach mucosa, D-cells possess cytoplasmic extensions con-
taining secretory vesicles that terminate near gastrin, pa-
rietal, and enterochromaffin-like cells, allowing D-cells
directly to inhibit the release of gastrin, gastric acid and
histamine, respectively (10–12). This inhibition is be-
lieved to bemediated largely via binding to theGi-coupled
SST receptor 2 on target cells (13).
Ultrastructural analyses have revealed that most
D-cells in the gastric corpus and antrum are open type
(14), allowing them to make direct contact with, and po-
tentially sense the composition of, the luminal contents.
Theoral ingestionof carbohydrate and thedigestionprod-
ucts of fat and protein have been shown to stimulate SST
release (15–17).Gut perfusion studies further showed that
the luminal presence of nutrients in the stomach is key to
SST secretion (18), suggesting that direct chemosensation
of foodstuffs provides an important mechanism by which
D-cells respond to changes in nutritive status, and act to
adjust luminal pH accordingly.
In addition to nutrient-based secretagogues, SST re-
lease from the stomach is controlled by the vagus nerve
and various enteric nervous system (ENS) neurotransmit-
ters. SST is persistently releasedbetweenmeals to suppress
interprandial acid secretion (2, 8). Activation of the effer-
ent vagus upon food ingestion inhibits SST release, via a
mechanism proposed to involve muscarinic M2 and M4
receptors expressed on D-cells (19), thereby releasing the
brake on gastrin, histamine and acid secretion (20, 21).
Towards the end of a meal, SST release is reinitiated,
switching off gastric acid secretion. Peptides produced by
the ENS that have been reported to stimulate SST release
include vasoactive intestinal polypeptide (VIP), calcitonin
gene-related polypeptide (CGRP), and pituitary adenylate
cyclase-activating peptide (PACAP) (22–24). Hormonal
signals from the small intestine and stomach, such as glu-
cagon-like peptide-1 (GLP-1), glucose-dependent insuli-
notropic polypeptide (GIP) (also known as gastric inhib-
itory polypeptide), cholecystokinin (CCK), and gastrin,
acting in addition to luminal signals such as pH, have also
been implicated in this mechanism (2, 25–29).
Although previous studies have identified a number of
hormonal, neural, and luminal signals that regulate SST
secretion, most laboratories have worked with intact an-
imals, whole perfused stomachs or gastric tissue pieces,
and in these systems it is difficult to distinguish which
stimuli act directly on D-cells and which exert indirect
effects mediated by the local ENS or endocrine cells. The
objective of this study was to investigate which of the
proposed mediators of SST release act through direct in-
teraction with D-cells. We developed a bacterial artificial
chromosome transgenic mouse model, SST-Cre, in which
the Sst promoter drives expression of Cre-recombinase.
When crossed with fluorescent reporter strains such as
ROSA26-enhanced yellow fluorescent protein (EYFP)
and ROSA26-GCaMP3, fluorescent labeling and intra-
cellular calcium sensor expression were restricted to the
D-cell population. By fluorescence-activated cell sorting
(FACS) purification and RNA sequencing analysis of D-
cells, we identified which stimuli are associated with the
expression of matching G protein-coupled receptors
(GPCRs). We used primary cultures of murine gastric ep-
ithelium, in which neural connections have been dis-
rupted, to assess the impact of different candidate stimuli
on SST secretion. Relevant stimuli were also tested in sin-
gle-cell, real-time calcium imaging experiments. Here, we
present the first transcriptomic characterization ofmurine
gastric D-cells and the elucidation of cellular machinery
responsible for the meal-dependent regulation of SST se-
cretion from the stomach.
Materials and Methods
Solutions
Unless otherwise stated, all chemicals were obtained from
Sigma-Aldrich. The standard bath solution contained 138
mmol/L NaCl, 4.5 mmol/L KCl, 4.2 mmol/L NaHCO3, 1.2
mmol/L NaH2PO4, 2.6 mmol/L CaCl2, 1.2 mmol/LMgCl2, and
10 mmol/L HEPES (pH 7.4; NaOH). Test reagents were pre-
pared as 1000 stocks. CCK, GLP-1, peptide YY (PYY) (all
Tocris Bioscience), CGRP, acetylcholine, and gastrin weremade
up in molecular biology grade water. VIP and bombesin (Tocris
Bioscience)were prepared in 1% (vol/vol) acetic acid.NPS2143-
HCl (Tocris Bioscience) andRo5166017 (Roche)were dissolved
in dimethyl sulfoxide. These stock solutions were diluted to the
final concentrations indicated. Peptone was prepared as a 0.5%
(wt/vol) solution in standard bath solution.
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Animals
Animal procedures were approved by the local ethics com-
mittee and conformed to the United KingdomHome Office reg-
ulations.Mice were killed via cervical dislocation, and stomachs
were collected into ice-cold Leibovitz-15 medium.
A detailed description of the generation of mice expressing
Cre-recombinase under the control of the Sst promoter is given
in the Supplemental Methods and Supplemental Figure 1A. In
brief,wemade transgenicmiceusing aNonobesediabetic-mouse
derived bacterial artificial chromosome in which the coding se-
quence for Sstwas replaced while retaining approximately 118-
kbp 5 and approximately 98-kbp 3 of the Sst-start and Sst-stop
codons, respectively. SST-Cre mice were crossed with ROSA26-
EYFP, ROSA26-tandem red fluorescent protein (tdRFP), and
ROSA26-GCaMP3 mice (30, 31), as indicated to produce dou-
ble or triple transgenic mouse lines. Male and female mice were
used interchangeably, in approximately equal numbers.
Immunohistochemistry
Freshly isolated mouse stomach or pancreas was fixed in 4%
(wt/vol) paraformaldehyde for 24 hours at 4°C and cryopro-
tectedvia sucrosegradient, startingwith15%sucrose for6hours
at room temperature and finishing with 30% sucrose for 24
hours at 4°C. The tissue was then embedded in optimum cutting
temperature compound before slicing. Tissue sections (7 m)
were blocked in 10%donkey serum, 0.05%Tween80 for 1hour
at room temperature. Sectionswere then incubatedwith primary
antibodies against SST (1:1000; Dako) and green fluorescent
protein (GFP) (1:1000; Abcam) overnight at room temperature
(for antibodies, see Table 1). Sections were rinsed with 5% don-
key serum, 0.05% Tween 80 before being incubated for 1 hour
at room temperature with Alexa Fluor 488 (1:300) and Alexa
Fluor 555 (1:300) secondary antibodies (Invitrogen). Tissue
stained with secondary antibodies only served as controls. Im-
ages were taken using a Zeiss LSM 710 META confocal micro-
scope with ZEN 2010 software (Carl Zeiss) using a 63x/NA 1.4
objective at an optical slice thickness of 1.0 m.
Primary stomach epithelium mixed cell culture
The antrum and corpus of the stomach was separated and
flushed with ice-cold PBS. The tissue was treated with 0.25-
mg/mL collagenase XI. Digested tissue was collected via centrif-
ugation at 100g, and isolated epithelial glandswere resuspended
in DMEM (25 mmol/L glucose) supplemented with 10% (vol/
vol) fetal bovine serum, 2 mmol/L L-glutamine, 100-U/mL pen-
icillin, and 100-g/mL streptomycin. This tissue suspensionwas
plated on matrigel (BD Biosciences-coated 24-well plates or
35-mm glass-bottom dishes; MatTek Corp), and incubated at
37°C under 5% CO2. For secretion assays, tissue from 3 mice
was combined into the same plate. This was performed by di-
gesting each stomach separately, then combining the pelleted
glands from all 3 stomachs before resuspending in 12.5 mL of
culture medium. A total of 500 L of this resuspension was
deposited into each well of 1 24-well plate.
SST secretion
Secretion assays were conducted on cultures 1 day after plat-
ing tissue on 24-well plates. Cultures were incubated with test
reagents made up in standard bath solution containing 0.1%
(wt/vol) fatty acid-free BSA and 10 mmol/L glucose for 2 hours
at 37°C. Hormone content in secretion samples was assayed
using an ELISA (SST ultrasensitive ELISA kit; Phoenix Pharma-
ceuticals, Inc). Due to variations in epithelial gland size and the
number of cells per gland, the number of cells seeded into each
well is unknown. To account for variation in D-cell number
between experimental replicates, the amount of SSTmeasured in
each well per 24-well plate was normalized to the average
amount of SSTmeasured inwells treatedwith control conditions
(3–4 wells per 24-well plate) measured in parallel in the same
plate on the same day, giving the fold change in SST secretion.
The average secretion of SST in control conditions across all
experiments was 27.4  1.8 pg per well. Each assay condition
was repeated in at least 3 wells per 24-well plate in at least 3
separate 24-well plates, each established from 3 murine
stomachs.
Calcium imaging
Stomach epithelial cells were imaged 1–2 days after plating.
Cells were loaded with 5 mol/L Fura-2 AM (Invitrogen) in
standard bath solution containing 300 mol/L eserine, 0.01%
(vol/vol) pluronic, and 10 mmol/L glucose for 30 minutes at
37°C. Experiments were performed using a Hamamatsu
Orca-ER digital camera (Cairn Research) attached to an Olym-
pus IX71 inverted fluorescent microscope (Southall) with a 40
oil-immersion objective. Gastric D-cells were identified by their
tdRFP expression when excited at 555/10 nm and collecting the
emission with a 570 long pass dichroic mirror. To measure in-
tracellular Ca2 levels, cells were excited at 340/16 and 380/8
nm (emission 510/80), and images were taken every 2 seconds
using a 75-W xenon arc lamp. Excitation and recording were
controlled using Metafluor software (version 7.6.5.0; MDS An-
alytical Technologies). Recordings were background subtracted
and represented as the 340/380 nm ratio. Primary cultures from
mice expressing the genetically encoded Ca2 indicator,
Table 1. Antibody Table
Peptide/Protein
Target
Antigen Sequence
(if known)
Name of
Antibody
Manufacturer, Catalog
Number, and/or Name
of Individual Providing
the Antibody
Species Raised in;
Monoclonal or
Polyclonal
Dilution
Used
SST Synthetic cyclin (1–14)
SST conjugated to
bovine thyroglobulin
Rabbit anti-SST Dako, A0566 Rabbit polyclonal 1:1000
GFP Recombinant full-length
GFP made in
Escherichia coli
Anti-GFP antibody Abcam, Ab5450 Goat polyclonal 1:1000
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GCaMP3, were imaged as above, except instead of loading with
fura 2, cells were allowed to equilibrate to room temperature for
10 minutes in standard bath solution before imaging. To mea-
sure intracellularCa2 levels, cellswere excited at 488/8nm, and
imageswere taken every 2 seconds using a 75-Wxenon arc lamp.
Emission was collected using a 510-nm long-pass filter. Record-
ingswere background subtracted and represented as the 488-nm
fluorescence intensity. Test reagents were perfused in standard
bath solution at a rate of approximately 1 mL/min. Average
fluorescence ratios/intensities were calculated over 10-second
time windows for the entirety of the experiment. Responses to
test reagents were calculated by determining the peak 340/380
(Fura-2) ratio or peak 488 fluorescence (GCaMP3) during per-
fusion of the test reagent divided by the average of the baseline
taken before and after test reagent application to give a fold
change value. Cells were included in the analysis if they re-
sponded to 30 mmol/L KCl.
Stomach epithelial cell isolation for flow
cytometry
After removal of the fundus, gastric epithelial cells were iso-
lated as previously described by Schepp et al (32). Cells were
immediately sorted by flow cytometry using a BD Influx cell
sorter (BD Biosciences) equipped with a 488 laser for detection
of EYFP. Cells were collected into RLT lysis buffer (QIAGEN)
and frozen on dry ice.
RNA extraction and quantitative RT-PCR (qPCR)
Total RNA was extracted using an RNeasy Micro kit
(QIAGEN), according to the manufacturer’s protocol. qPCR
was performed with a 7900 HT Fast Real-Time PCR system
(Applied Biosystems). The PCR reaction mix consisted of first-
strand cDNA template, primer pairs, 6-carboxyfluorescein/
quencher probes (Bioresearch Technologies andApplied Biosys-
tems), and PCR Master mix (Applied Biosystems), and was
amplified for 40 cycles. No-template controls were included for
all primers. Expression of selected targets was compared with
that ofActbmeasured on the same sample in parallel on the same
plate, giving a CT difference (CT) forActbminus the test gene.
Mean, SE, and statistics were performed on the CT data and
only converted to relative expression levels (2ˆCT) for presen-
tation in the figures.
RNA sequencing
Total RNA was extracted using an RNeasy Micro Plus kit
(QIAGEN) according to the manufacturer’s instructions. The
quality of the RNA extracted was checked using a Bioanalyser
RNA Pico kit (Agilent) with RNA integrity number values be-
tween 7.2 and 9.4. RNAwas amplified using Ovation RNA-seq
System V2 (NuGEN), whereby 2.5 ng of RNA for each sample
were used (note 4 replicates were used each for D-cells and con-
trol cells, totaling8 samples).Toprepare theRNAseq library, the
amplified cDNA (3 g per sample) was fragmented to 200 bp
using the Bioruptor Sonicator (Diagenode), and barcode ligation
and end repair were achieved using the Ovation Rapid DR Li-
brary System (NuGEN). The barcoded libraries were combined
and sent for SE50 sequencing using an Illumina HiSeq 2500
systemat theGenomicsCoreFacility,CancerResearchUKCam-
bridge Institute.
Data analysis
All statistical analysis was conducted using Microsoft Excel
and GraphPad Prism 5.0 (GraphPad Software, Inc). Statistical
significance was calculated using a Student’s single-sample or
2-sample t test or via ANOVAwith either a Dunnett’s or a Bon-
ferroni post hoc test, as appropriate. The threshold for signifi-
cance was set as P  .05. Sequence reads were demultiplexed
using the Casava pipeline (Illumina) and then aligned to the
mouse genome (GRCm38) using Tophat version 2.0.11 (http://
ccb.jhu.edu/software/tophat/index.shtml). Differential gene ex-
pression was determined using Cufflinks version 2.2.1 (http://
cole-trapnell-lab.github.io/cufflinks/).
Results
Generation and validation of SST-Cre mice
SST-Cre/ROSA26tdRFP/EYFPmicewere found to exhibit
EYFP fluorescence that, in the stomach, was restricted to
a subpopulation of cells. Cre recombinase efficiency in the
stomach was assessed by quantifying the number of SST
producing cells coexpressing EYFP via immunohisto-
chemistry. In whole-stomach slices, costaining with anti-
bodies against SST and EYFP revealed that 59% of SST-
positive cells stained for EYFP and 91% of EYFP labeled
cells were positive for SST (Figure 1, A and B, and Sup-
plemental Figure 1, B and C). The percentage colocaliza-
tionwas also assessed in primary gastric epithelial cultures
from SST-Cre/ROSA26tdRFP mice, revealing that 80% of
SST-positive cells contained RFP and 91% of RFP-ex-
pressing cells were positive for SST (225 cells counted in
total, from 2 separate preparations, each containing
pooled tissue from 4 transgenic mice) (Supplemental Fig-
ure 1D). This confirmed that transgene expression was
largely restricted to cells producing SST, but indicated that
Cre-recombinase actionwas not fully efficient and labeled
60%–80% of D-cells.
Slices of whole pancreas were also examined for trans-
gene expression (Figure 1C). Staining for EYFP was
largely isolated to SST-producing -cells. Importantly, no
labeling was detected in the surrounding exocrine tissue
where SST expression is known not to occur (Supplemen-
tal Figure 1E) (33).
FACS purification and expression analysis of
D-cells
SST-Cre/ROSA26EYFPmice were used to purify D-cells
by flow cytometry from epithelial digests of the gastric
antrum and corpus based on their cell-specific fluores-
cence and low side scatter (Supplemental Figure 2). Con-
trol nonfluorescent cell populations were collected in par-
allel using stringent forward and side scatter gating that in
pilot FACS analysis experiments was found to exclude
cells that were YFP positive but SST negative. qPCR anal-
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ysis of the relative expression of Sst in the EYFP positive
and EYFP negative populations revealed a 690-fold (P 
.001) enrichment of Sst message in the EYFP positive
population.
We next performed RNA sequencing (RNA-seq) anal-
ysis of these isolated D-cells and control populations to
identifyhormones,GPCRs, andother receptors thatmight
underlie the behavior and modulation of gastric D-cells.
The average total number of reads per sample was 11
million, with an average of 9.4 million reads mapping to
the mouse genome, thereby resulting in a mapping effi-
ciency of 85.7%. Using a fold change cut-off of 2, a false
discovery rate of 0.1, and a sensitivity threshold for ex-
pression of more than 1 fragment per kilobase per million
mapped reads (FPKM), RNA-seq analysis found that
3143 geneswere differentially expressed between Sst-pos-
itive and Sst-negative cell populations (Figure 2 and Sup-
plemental Dataset 1). Expression of key targets selected
from this list was confirmed by qPCR (Figure 3 and Sup-
plemental Figure 4).
RNA-seq analysis revealed that transcript levels for
Pyy,Gip,Ppy,Cck, and Iapp (amylin)were all enriched in
D-cells over neighboring epithelial cells (Table 2), indi-
cating a possible coproduction of these peptides with SST,
and potential heterogeneitywithin the SST-expressing cell
population. D-cell expression of these hormones was con-
firmed by qPCR, although even the most abundant alter-
native hormonal transcript (Pyy) was found at approxi-
mately 30-fold lower levels than Sst (Figure 3A).
RNA-seq analysis identified a number of gut hormone
receptor transcripts with FPKM values of more than 1 in
D-cells, specifically receptors for GLP-1 (Glp1r), GIP
(Gipr), CCK (Cckar), and the SST receptors Sstr1, Sstr2,
and Sstr3, whereas D-cell CCK-B receptor (Cckbr) tran-
scripts were very few. qPCR data confirmed these expres-
sion patterns forGlp1r,Gipr,Cckar, andCckbr. Of note,
the expression of Gipr was largely D-cell specific, with
D-cell expression levels nearly 100-fold higher than in
neighboring cells (P .001). The finding that Cckbr was
barely detectable in D-cells indicates that Cckar is the
dominantCCK receptor familymember in these cells (Fig-
ure 3B).
The expression of receptors for prominent neurotrans-
mitters in the gut was also examined. Receptors for the
neuropeptidesVIPandPACAP(Vipr1),CGRP(Calcrland
Ramp1), and galanin (Galr1) were detected and enriched
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Figure 1. Confirmation of cell-specific transgene expression. A,
Corpus/antral tissue isolated from transgenic mice expressing EYFP
under the control of the Sst promoter was fixed, sliced, and stained for
EYFP (green) and SST (red). Blue represents Hoechst staining. B, We
counted 158 cells that were stained for EYFP and/or SST. The number
of cells that were stained for SST only (gray), EYFP only (white), or both
(black) are expressed as a percentage of all fluorescent cells counted.
Figure 1. (continued). These data were obtained from 4 sections of
whole stomach from one transgenic mouse. C, To investigate
transgene expression in other areas known to express SST, slices of
whole pancreas from mice expressing EYFP under the control of the
Sst promoter were stained for EYFP (green) and SST (red). Blue
represents Hoechst staining.
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in D-cells. qPCR confirmed that D-cells expressed signif-
icantly higher levels of Vipr1 (P  .01), Calcrl (P  .01),
andRamp1 (P .01) than non-D-cells. In contrast, mem-
Figure 2. Heatmap showing differential expression of genes between SST
positive and negative gastric epithelial cells. Single-cell digests of gastric
mucosa from the antrum and corpus of SST-Cre x ROSA26EYFP/EYFP mice were
passed through a FACS sorter and gastric D-cells were purified based on their
green fluorescence. RNA from 4 EYFP-positive and 4 EYFP-negative cell
samples was sequenced using SE50 sequencing. Reads were aligned to the
GRCm38mouse genome using Tophat version 2.0.11. Differential gene
expression was determined using Cufflinks version 2.2.1. The heatmapwas
generated using the following selection criteria: fold change of more than 2,
false discovery rate 0.1, and FPKM values of more than 1, and was subjected
to hierarchical clustering based on Euclidean distance and average linkage. A
total of 3143 genes were differentially expressed. More information on these
genes can be found in Supplemental Dataset 1.
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Figure 3. Gene expression in SST-positive and SST-negative cells measured
by qPCR. Histograms showing relative gene expression of peptide hormones
(A), peptide hormone receptors (B), neurotransmitter receptors (C), and
nutrient receptors (D) in SST-positive (white bars) and SST-negative (black bars)
cells. Expression was analyzed by qPCR and compared with that ofActb in the
same sample. Each column represents 3 samples from separate mice. Samples
where target genes were undetected were assigned Ct values of 40. Data are
presented as the geometric mean, with error bars calculated from log(base2)
data. Significance comparisons between SST-positive and SST-negative cells
were calculated by Student’s t test performed on the nontransformedCT
data; ns, not significant; *, P .05; **, P .01; ***, P .001.
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bers of the bombesin receptor family (Bb1–3) exhibited
FPKM values of less than 0.2, suggesting they are rela-
tivelypoorly expressed.Of themuscarinic receptor family,
we detected high, D-cell-specific expression of Chrm4
(M4) and lowexpressionofChrm3 (M3),whereas levels of
Chrm1, Chrm2, and Chrm5 in D-cells were very low.
Among the glutamate receptor family, we observed high
D-cell-specific expression of the ionotropic glutamate re-
ceptor, Gria2, and moderate to low levels of the kainite
receptor Grik5 in both D-cells and their neighbors. Ex-
pression of histamine receptor family members (Hrh) in
D-cells was also very low (Table 2). Again, qPCR analysis
revealed good correlation with the RNA-seq findings:
expression of Gria2, Grik5, Chrm3, and Chrm4 was
confirmed, and levels ofGria2,Grik5, andChrm4were
significantly higher in D-cells than their neighbors (Fig-
ure 3C).
Because SST release is regulated in vivo by luminal pro-
teindigestion,weexaminedD-cell expressionof candidate
receptors for oligopeptides and amino acids. One of the
most highly enriched D-cell transcripts,Casr, encodes the
calcium-sensing receptor (CASR), a GPCR capable of
sensing extracellular Ca2, aromatic amino acids, and oli-
gopeptides (34, 35). The lysophosphatidic acid receptor 5,
LPAR5 (GPR92/93), previously implicated in peptone
sensing by EECs, was also identified in D-cells by RNA-
seq. Of the candidate amino acid sensors, we did not find
high levels of anymembers of themetabotropic glutamate
receptor family, the umami receptor subunit (Tas1r1) or
Gprc6a. D-cells did, however, express high levels of the
trace amine receptor Taar1, a GPCR known to bind trace
amines, products of the decarboxylation of amino acids
found in fermented foodstuffs (Table 2) (36). By qPCR
analysis, bothTaar1 andCasrwere confirmed to beD-cell
specific (P .01 andP .001, respectively): expression of
Casrwas almost 80-fold greater in D-cells vs neighboring
cells, whereas Taar1 expression was 13-fold higher in D-
cells (Figure 3D).
Identification of stimuli affecting SST release and
D-cell intracellular Ca2 activation
In order to establish a functional role for the receptors
found to be enriched in RNA-seq and qPCR analyses, pri-
mary cultures of the mouse gastric antrum epithelium
were maintained for approximately 24 hours and then
stimulated for 2 hours with candidate stimuli.
The incretin peptides, GIP and GLP-1 (100 nmol/L
each), evoked significant increases in SST secretion (5.4-
fold, P  .001; 2.6-fold, P  .001, respectively) (Figure
4A), andCCKenhancedSSTsecretion1.8-fold (P .001).
In agreement with the gene expression data, gastrin failed
to stimulate SSTrelease fromprimary cultures (Figure4B).
CCK-A andCCK-B are Gq-coupled receptors (37), and
their activation should therefore trigger phospholipase-
C-dependent release of intracellular Ca2 stores. By
Fura-2 imaging, Ca2was found to be elevated byCCK in
7 out of 11 D-cells (mean 1.12-fold increase in fluores-
cence ratio,P .01, for responding cells only) (Figure4C),
indicating direct regulation of D-cells by CCK. In agree-
Table 2. RNA Sequencing Analysis of Select Genes
Expressed in Gastric D-Cells and Neighboring Gastric
Epithelial Cells
SST Positive
(FPKM)
SST Negative
(FPKM)
Coexpressed hormones
Sst 82 900  12 200 242  34
Pyy 5260  963 17.2  4.9
Ppy 114  18 0.55  0.20
Iapp 38.8  6.1 0.68  0.59
Gip 67.7  18.3 0.24  0.14
Cck 37.2  10.1 0.52  0.22
Hormone receptors
Glp1r 8.23  1.35 11.7  2.7
Gipr 1.96  0.32 0.02  0.02
Cckar 3.53  0.41 23.5  6.7
Cckbr 0.19  0.09 1.84  0.72
Sstr1 1.93  0.84 0.02  0.02
Sstr2 1.01  0.17 1.81  1.22
Sstr3 2.99  0.62 0  0
Sstr4 0  0 0  0
Sstr5 0.02  0.01 0.01  0.01
Neurotransmitter receptors
Vipr1 2.00  1.47 0.07  0.07
Calcrl 50.9  10.2 0.76  0.25
Ramp1 22.2  2.3 0.68  0.08
Galr1 1.62  0.33 0.07  0.05
Nmbr (Bb1) 0.07  0.07 0  0
Grpr (Bb2) 0.09  0.07 0  0
Brs3 (Bb3) 0  0 0  0
Gria2 6.00  1.07 0.02  0.02
Grik5 1.12  0.38 0.07  0.04
Chrm1 0.12  0.05 0.80  0.13
Chrm2 0.04  0.03 0  0
Chrm3 0.43  0.06 0.32  0.12
Chrm4 9.80  2.01 0.03  0.03
Chrm5 0  0 0.04  0.04
Hrh1 0  0 0.01  0.01
Hrh2 0.47  0.11 0.76  0.23
Hrh3 0.27  0.10 0  0
Hrh4 0  0 0  0
Gabbr1 11.8  3.1 0.97  0.43
Gabra1 3.69  0.44 0.03  0.01
Gabrb3 35.3  3.2 0.48  0.16
Nutrient-derived factor
receptors
Casr 7.32  1.69 0.03  0.03
Taar1 6.81  0.85 0.04  0.04
Gpr92/Lpar5 2.85  1.12 2.08  1.03
Gprc6a 0.12  0.06 0  0
Tas1r1 0.01  0.01 0.01  0.01
Data are averaged FPKM values for genes of interest. Data are
representative of 4 samples each from 4 separate mice for SST positive
and negative cells.
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ment with the gene expression and secretion assay data,
100 nmol/L gastrin failed to elevate D-cell Ca2 (data not
shown).
Strong SST secretory responses were observed after ap-
plication of a number of neurotransmitters. CGRP (100
nmol/L) stimulated secretion 4.6-fold (P .001), and VIP
(100 nmol/L) elicited a 2.3-fold increase in SST release
(P  .001). No significant response was observed with
bombesin, an analog of gastrin-releasing peptide (GRP),
in accordance with the lack of expression of bombesin
receptors in the RNA-seq data (Figure 5A). Acetylcholine
(10 mol/L) proved to be a potent inhibitory influence on
SST release. When applied in basal conditions, acetylcho-
line decreased SST levels by approximately 45% (P 
.001), and in the presence of 100 mol/L 3-isobutyl-1-
methylxanthine (IBMX), acetylcholine decreased SST se-
cretion to below basal levels (P .001) (Figure 5B). Ace-
tylcholinewhen applied in the presence of 100nmol/LGIP
also decreased SST secretion to basal levels (P  .001)
(Figure 5B).
Peptone (0.5% wt/vol), an enzymatic meat hydroly-
sate, elicited a1.9-fold increase in SST secretion (P .001)
that was significantly inhibited by the CASR antagonist
NPS2143 (5 mol/L, P  .001) (Figure 6A). We also ex-
amined the potential effect of trace amines, a subgroup of
biogenic amines derived from amino acid metabolites
(36). Agonism of trace amine-associated receptor 1
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(TAAR1) using 50 nmol/L Ro5166017 (38) elicited a
strong 4.5-fold increase in SST secretion (P  .001) (Fig-
ure 6B).
To examine the putative direct effect of peptones onD-cells
via the Gq-coupled CASR (39), we employed a novel triple
transgenic mouse strain, SST-Cre/ROSA26tdRFP/GCaMP3 ex-
pressing tdRFP and the genetically encoded calcium indi-
cator GCaMP3 specifically in the D-cell population. In
pilot experiments in which we recorded simultaneously
from fura 2 and GCaMP3, similar responses in gastric
D-cells were recorded using the 2 techniques (Supplemen-
tal Figure 5). Further exploration of the D-cell Ca2 re-
sponse to peptone (0.5%wt/vol) using GCaMP3 imaging
revealed that 12/38 cells responded with an increase in
intracellular Ca2 (1.74-fold increase in fluorescence,P
.001) (Figure 6C).
Discussion
Cre-mediated labeling of SST-producing cells
Our use here of SST-Cre mice has enabled the identi-
fication and single-cell characterization of gastric D-cells.
Immunohistochemical analysis confirmed that the SST-
Cre line correctly labeledD-cells in the gastricmucosa and
endocrine pancreas. We found the Cre penetrance of this
mouse line did not enable the labeling of all gastric SST-
producing cells, in accordance with a previous study re-
porting 80% efficiency of Cre-dependent reporter expres-
sion in the pancreas (40). Despite moderate labeling
efficiency, this SST-Cre mouse line is the first to permit
FACS-based purification of gastric D-cells for transcrip-
tomic analysis as well as the real-time imaging of D-cell
Ca2 responses.
A caveat for the use of thismouse line in transcriptomic
analysis of FACS-purified SST positive and negative pop-
ulations is that 1) not all SST-producing cells were labeled
by the fluorescent reporter and 2) a small subset of fluo-
rescently labeled cells did not stain for SST. The impact of
the former is that we might not have captured all D-cell
RNAs if the fluorescent labeling of SST-positive cells was
nonrandom. To reduce the impact of the latter, we per-
formed early pilot FACS analysis experiments using fixed
and permeabilized stomach epithelial cells immunohisto-
chemically double stained for EYFP and SST, which re-
vealed that SST-positive cells could be distinguished from
EYFP-positive/SST-negative cells by their characteristic
low side and forward scatter. A low forward/side scatter
gate was therefore used during FACS sorting to optimize
the purity of the D-cell population and resulted in nearly
700-fold enrichment for SST expression in positive com-
paredwith negative populations. The negative population
is predicted to contain amixture of stomach epithelial cell
types, including chief and parietal cells, G-cells, and en-
terochromaffin-like cells, but due to the constrained for-
ward and side scatter gates used to collect SST-negative
cells, not all stomach epithelial cell types may be repre-
sented in the negative population.
Consistent with previous reports showing that many
EECs express a variety of regulatory hormones (41), D-
cells also expressed transcripts for Pyy, Ppy, Iapp, Gip,
and Cck, albeit at low levels. Although our data do not
indicate whether these transcripts arise from all D-cells
or only subpopulations, previous studies looking at
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PYY-associated immunoreactivity in the gut reported
that a subset of D-cells in the gastric mucosa costained
for PYY (42).
Hormonal regulation of D-cells
In our primary stomachmixed epithelial cultures, both
GLP-1 and GIP enhanced SST release, consistent with a
previous study using perfused rat stomachs that reported
a stimulation of SST secretion by GLP-1 (26). The perfu-
sion experiments similarly concluded that this stimulation
was likely to be a direct effect on enteroendocrine D-cells
rather thanmediated by the stimulation of SST-producing
nerves, because tetrodotoxinhadnoeffect onGLP-1-stim-
ulated SST release (26). Studies in perfused rat stomach
also found that GIP infusion stimulated SST release (29),
whichwas abolishedbyacetylcholineor stimulationof the
vagus nerve (29), mirroring our secretion results. Al-
though we cannot rule out the role of paracrine signaling
in our primary mixed culture secretion assays, taken to-
gether with our D-cell mRNA expression data, these re-
sults support the idea that incretin hormones directly stim-
ulateD-cells. If gastric SST is capable of reaching themore
distal L- and K-cell populations, this in turn might result
in a feedback inhibition of GLP-1 and GIP release. A neg-
ative feedback loop involving SST has also been suggested
in previous studies: in humans, treatment with GLP-1 mi-
metics or dipeptidyl peptidase-4 inhibitors results in lower
endogenous GLP-1 release (43), and in pig perfused in-
testine, antagonists of SST receptors increased GLP-1 se-
cretion (44).
Both incretins have been found to decrease gastric
acid production (45), and in perfused rat stomachs ad-
dition of GLP-1 led to a concomitant drop in gastrin
production alongside SST stimulation. This combined
with our secretion data could suggest that the inhibitory
effect of incretins on gastric acid secretion is partly me-
diated by SST (26).
CCK and gastrin share an amidated carboxy-terminal
pentapeptide sequence (46) andbind the sameCCK-Aand
CCK-B receptors, with gastrin preferentially binding
CCK-B (47–49). Both CCK-A and CCK-B are present in
theGI tract, includingmucosal cells (46, 47, 50).Although
previous literature suggested that both gastrin and CCK
elicit SST release from the stomach (47, 51–54), in our
primary epithelial cultures, CCKbut not gastrin increased
SST secretion and intracellular Ca2 in D-cells. These
functional results were supported by our gene expression
data indicating the presence of CCK-A but not CCK-B
receptors inD-cells.Our results are consistentwith a num-
ber of other previous findings. Immunostaining in human
gastric samples, for example, confirmed the presence of
CCK-A but not CCK-B receptors in SST-positive cells
(46), and CCK has been reported to act through CCK-A
receptors in cultures of canine fundicD-cells, leading to an
increase in SST secretion (28, 55, 56). Studies suggesting
that gastrin stimulates SST release via a negative feedback
loop involving CCK-B receptors, have mostly been per-
formed in whole tissues, and could not distinguish
whether the CCK-B receptors were located directly on D-
cells (57). Our results rather suggest that any effects of
gastrin on SST secretion are likely to be indirect, involving
CCK-B receptors on a different cell type.
Neural regulation of D-cells
The stomach is densely innervated by the ENS, as well
as processes of extrinsic neurons. In our secretion assays,
several neurotransmitters proved to be effective stimuli or
inhibitors of SST release, highlighting the potential im-
portanceof neural factors in regulating gastric physiology.
CGRP, for example, was an effective stimulus for SST
secretion, correlating with high D-cell expression of the
CGRP receptor subunits calcrl and ramp1. These results
support studies showing that activation of D-cells by low
pH relies on the stimulation ofCGRP-releasing peripheral
sensoryafferentnerve endings in the stomach (24). Indeed,
a pathway involving CGRP release triggered by low pH
could underlie the indirect elevation of SST release by
gastrin.
Immunoreactivity for VIP can be found in nerve fibers
interspersed between antral glands (58), and VIP has been
shown to augment SST release and decrease gastric acid
secretion in perfusion studies (58). In our mixed cultured
epithelial cells, VIP stimulated SST secretion, and vipr1
expression was significantly enriched in purified D-cells.
Although not tested in our culture system, PACAP-38,
producedby enteric neuronal cell bodies that innervate the
gastric smoothmuscle layer andmucosa, is also known to
bind VIPR1 (59), and perfusion studies in mice have
shown that PACAP-38 inhibits pentagastrin-triggered
acid secretion via SST release (59). Our data suggest that
VIPR1 located on D-cells could underlie these observed
effects of PACAP-38 and VIP.
GRP is a neurotransmitter present in themucosal nerve
fibers of the fundus and antrum (60), and directly stimu-
lates the release of gastrin from G-cells (61). Contrary to
previous findings that GRP increased SST release from
perfused rat stomach (62),we foundno evidence for direct
effects of GRP/bombesin on D-cells. Other studies have
come to a similar conclusion (61, 63, 64), and some per-
fusion studies have suggested that the effects of bombesin/
GRPon SST release aremainly indirect, perhaps involving
the release of a noncholinergic stimulatory transmitter
(57). Secretion assays in our mixed stomach epithelial cell
cultures support the role of a neurotransmitter interme-
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diary, because paracrine signaling between epithelial cells
types might still be intact in our culture system, whereas
neural regulation should be disrupted.
Acetylcholine proved to be a strong inhibitory factor in
our secretion assays, consistent with extensive literature
indicating that SST release is under cholinergic control.
Until now it was not, however, clear which muscarinic
receptors are responsible for direct cholinergic inhibition
ofD-cells. Of themuscarinic receptor family, onlyM2 and
M4 are coupled to Gi proteins, whereas M1, M3, and M5
are predominantly Gq coupled. Our expression data sug-
gest that Chrm4 (M4) is the predominant inhibitory mus-
carinic receptor expressed in D-cells, although further
functional assays are needed to confirm this.
Histamine is also purported to be a negative regulator
of SST release acting through the H3 receptor, because
perfusion studies in rat stomach using H3 antagonists
showed an increase in SST release (65). In our RNA-seq
data, however, transcripts for histamine receptors were
not detected to an appreciable degree, consistentwith pre-
vious immunohistochemical evidence that failed to detect
H3 in gastric D-cells (66). The effect of histamine on SST
release is therefore likely to be indirect.
Nutrient regulation of D-cells
A variety of receptors and transporters have been sug-
gested to play a role in the chemosensation of protein
digestion products by EECs. Several studies have impli-
cated the Gq-coupled CASR in the detection of oligopep-
tides andaromatic aminoacids (34, 35, 67, 68), and recent
immunohistochemical analysis confirmed the presence of
CASR in the gastric antrum, including in a subset of antral
D-cells in mouse, swine, and human tissue (69). Our data
show that Casr is highly and specifically expressed in D-
cells and that the secretion of SST from cultured stomach
epithelium in response to 0.5%peptones is sensitive to the
specific CASR antagonist, NPS2143. These results point
towards a role for CASR in D-cell peptone detection.
Other receptors that have been implicated in amino
acid and oligopeptide detection include umami taste re-
ceptors (Tas1R1/3), metabotropic glutamate receptors,
GPRC6A and GPR92 (LPAR5). Immunohistochemistry
analysis has found that in addition to CASR, D-cells
costain for GPR92 and GPRC6A (69, 70). Gastric cell
fractionation studies found that SST-enriched fractions
also expressed mRNAs for the metabotropic glutamate
receptor (mGluR) subunits 2, 3, 4, and 7 (35, 71, 72).
Although D-cell transcript levels for Tas1R1, GPRC6A
andmGluRs in our RNA-seq analysis were very low, sug-
gesting they are unlikely to be expressed in D-cells, lpar5
was present in both D-cells and neighboring epithelial
cells.
Although oligopeptides also stimulate gastrin release
during early stages of protein breakdownand therebypro-
mote gastric acid release, a rising concentration of protein
digestion products in the gastric antrum could signal to
D-cells thatdigestionhasproceededbeyondacertain stage
and that acid production can now be switched off.
Trace amines
The trace amine receptor, TAAR1, was identified as a
D-cell-specific GPCR in both RNA-seq and qPCR analy-
sis. This Gs-coupled receptor has been shown to recognize
the trace amines tyramine and -phenylethylamine, as
well as other biogenic amines (38, 73). Although most
studies addressingTAAR1activity have focusedon its role
in neurotransmission, both qPCR and experiments ex-
ploring the binding sites of a radio-labeled 3-iodothyro-
namine, a potent natural agonist of TAAR1, have con-
firmed the presence of TAAR1 in the stomach (74).
Because trace amines have been shown to be present at
high levels in protein-rich substrates like meat and cheese,
the ingestion of such foods might provide a plausible
mechanism for the delivery of trace amines to the stomach
lumen (75). The TAAR1-specific agonist Ro5166017 al-
lowed for selective examination of TAAR1-mediated ef-
fects onD-cells, andwe confirmed that TAAR1 activation
robustly triggered SST release. Further work needs to be
done to ascertain which naturally occurring trace amines
affect SST secretion, but these findings have identified a
novel mechanism by which food components could mod-
ulate gastric and intestinal function.
Conclusion
The integration of neural, hormonal, and nutritional sig-
nals is critical for the coordination of digestion, nutrient
absorption, and the secretion of regulatory peptides. SST
provides anon/off switch for gastric acid secretion thathas
implications for the efficiency of digestion, as well as the
protection against luminal acidosis. Our in depth tran-
scriptomic and functional characterization of D-cells and
their modulation by regulatory peptides, neurotransmit-
ters, and dietary stimuli not only improves our under-
standing of gastric D-cells but promises to inform future
studies focused on targeting D-cell activity.
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